Neurocrine Biosciences, Inc.
Methods for the Administration of Certain VMAT2 Inhibitors

Abstract:

Provided is a method of administering a vesicular monoamine transport 2 (VMAT2) inhibitor to a patient in need thereof, wherein the patient experiences one or more clinically significant parkinson-like signs or symptoms.